Ledger.Open graph →
SEC Form D · filed September 29, 2021

ALPINE IMMUNE SCIENCES, INC

Offering
$91.0M
Sold
$91.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Stanford P. Peng · SEATTLE, WAExecRobert P. Conway · SEATTLE, WADirectorPeter P. Thompson · SEATTLE, WADirectorJay P. Venkatesan · SEATTLE, WADirectorZelanna P. Goldberg · Seattle, WAExecNatasha P. Hernday · Seattle, WADirectorJames P. Rickey · Seattle, WAExecCui P. Xiangmin · SEATTLE, WADirectorMitchell P. Gold · Seattle, WAExec · DirectorJames P. Topper · SEATTLE, WADirectorChristopher P. Peetz · SEATTLE, WADirectorStanford P. Peng · SEATTLE, WAExecRobert P. Conway · SEATTLE, WADirectorPeter P. Thompson · SEATTLE, WADirectorJay P. Venkatesan · SEATTLE, WADirectorZelanna P. Goldberg · Seattle, WAExecNatasha P. Hernday · Seattle, WADirectorJames P. Rickey · Seattle, WAExecCui P. Xiangmin · SEATTLE, WADirectorMitchell P. Gold · Seattle, WAExec · DirectorJames P. Topper · SEATTLE, WADirectorChristopher P. Peetz · SEATTLE, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗